This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CSX (CSX) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CSX (CSX) delivered earnings and revenue surprises of 14.29% and 2.97%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Canadian Pacific (CP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Canadian Pacific (CP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights Eli Lilly, Thermo Fisher Scientific, Lockheed Martin, Boston Scientific and Canadian Pacific Railway
by Zacks Equity Research
Eli Lilly, Thermo Fisher Scientific, Lockheed Martin, Boston Scientific and Canadian Pacific Railway are part of the Zacks top Analyst Blog.
Top Analyst Reports for Eli Lilly, Thermo Fisher Scientific & Lockheed Martin
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Thermo Fisher Scientific Inc. (TMO) and Lockheed Martin Corporation (LMT).
CSX Signs Deal Related to Paid Sick Leave With IBEW Union
by Zacks Equity Research
The latest deal with International Brotherhood of Electrical Workers, the seventh one between CSX and rail unions, marks CSX's favorable terms with unions.
Canadian National (CNI), Unifor Sign Tentative Collective Deals
by Zacks Equity Research
The announcement of new tentative collective deals with Unifor marks Canadian National's (CNI) favorable terms with unions.
Canadian Pacific (CP), TCRC-MWED Ink Tentative Collective Deal
by Zacks Equity Research
The announcement of a new tentative collective deal with the Teamsters Canada Rail Conference Maintenance of Way Employees Division marks Canadian Pacific's (CP) favorable terms with unions.
Canadian Pacific (CP) Stock Gets a Boost from U.S. Regulator
by Zacks Equity Research
The approval of Canadian Pacific???s (CP) buyout of Kansas City Southern is expected to result in multiple job creations.
Strength Seen in Canadian Pacific (CP): Can Its 5.7% Jump Turn into More Strength?
by Zacks Equity Research
Canadian Pacific (CP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
The Zacks Analyst Blog Highlights AbbVie, NextEra Energy, ConocoPhillips, Canadian Pacific Railway and Intercontinental Exchange
by Zacks Equity Research
AbbVie, NextEra Energy, ConocoPhillips, Canadian Pacific Railway and Intercontinental Exchange are part of the Zacks top Analyst Blog.
Top Research Reports for AbbVie, NextEra Energy & ConocoPhillips
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), NextEra Energy, Inc. (NEE) and ConocoPhillips (COP).
Here's Why You Should Retain Canadian Pacific (CP) Stock Now
by Zacks Equity Research
Canadian Pacific's (CP) efforts to reward its shareholders through dividends bode well.
Canadian Pacific (CP) Down 1.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Canadian Pacific (CP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights Union Pacific, Canadian Pacific Railway and CSX
by Zacks Equity Research
Union Pacific, Canadian Pacific Railway and CSX have been highlighted in this Industry Outlook article.
3 Railroad Stocks to Watch From a Challenging Industry
by Maharathi Basu
The Zacks Industry Rank for the Transportation-Rail industry paints a dull picture. Braving the industry headwinds are three stocks, UNP, CP and CSX, which you might consider keeping in your watchlist.
The Zacks Analyst Blog Highlights Microsoft, Cisco Systems, Target, Fomento Economico Mexicano, Canadian Pacific Railway and Las Vegas Sands
by Zacks Equity Research
Microsoft, Cisco Systems, Target, Fomento Economico Mexicano, Canadian Pacific Railway and Las Vegas Sands are included in this Analyst Blog.
Canadian Pacific (CP) Stock Up 0.3% on Q4 Earnings Beat
by Zacks Equity Research
Canadian Pacific's (CP) fourth-quarter 2022 earnings and revenues increased year over year.
Canadian Pacific (CP) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Canadian Pacific (CP) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Canadian Pacific (CP) Q4 Earnings Top Estimates
by Zacks Equity Research
Canadian Pacific (CP) delivered earnings and revenue surprises of 2.53% and 1.15%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Norfolk Southern (NSC) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Norfolk Southern (NSC) delivered earnings and revenue surprises of 0.29% and 1.88%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Canadian National (CNI) Q4 Earnings Lag Estimates
by Zacks Equity Research
CN (CNI) delivered earnings and revenue surprises of -0.64% and 0.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Canadian Pacific (CP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Canadian Pacific (CP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Canadian Pacific (CP) Announces Tentative Deal With Unifor
by Zacks Equity Research
The announcement of the new tentative collective deal with Unifor should provide a sense of relief for Canadian Pacific (CP).
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Starbucks, Moderna, Canadian Pacific Railway and Micron Technology
by Zacks Equity Research
Thermo Fisher Scientific, Starbucks, Moderna, Canadian Pacific Railway and Micron Technology are included in this Analyst Blog.
Top Stock Reports for Thermo Fisher Scientific, Starbucks & Moderna
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), Starbucks Corporation (SBUX) and Moderna, Inc. (MRNA).